Suppr超能文献

大鼠血清胰岛素样生长因子结合蛋白复合物酸不稳定亚基的体内调节

Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex.

作者信息

Dai J, Baxter R C

机构信息

Department of Medicine, University of Sydney, New South Wales, Australia.

出版信息

Endocrinology. 1994 Dec;135(6):2335-41. doi: 10.1210/endo.135.6.7527331.

Abstract

The acid-labile subunit (ALS) and insulin-like growth factor (IGF)-binding protein-3 are glycoproteins that form a complex carrying about 90% of the circulating IGFs. This study investigates the regulation of ALS expression by Northern hybridization, and serum ALS levels by RIA, in the rat. Northern analysis of ALS messenger RNA (mRNA) from adult rat brain, heart, lung, muscle, spleen, testis or ovary, kidney, and liver showed a liver-specific predominant 2-kilobase transcript. The steady state abundance of rat ALS mRNA was greatly reduced in neonatal and weanling liver compared to adult liver, with an age dependence similar to that of rat serum ALS levels. Fasting for 24 or 48 h decreased serum IGF-I and ALS levels, but not hepatic ALS mRNA. Streptozotocin-diabetic rats, untreated or treated with human GH for 5 days, had significantly decreased serum ALS levels and liver ALS mRNA abundance. Insulin treatment normalized serum ALS without fully restoring ALS mRNA. Dexamethasone, an inhibitor of ALS synthesis by hepatocytes, significantly reduced both serum ALS and hepatic ALS mRNA. The discrepancies between hepatic expression and serum ALS levels in fasting and diabetes point to a complex regulatory mechanism in which events at the translational level or later may be as important as regulation of gene expression or mRNA stability.

摘要

酸不稳定亚基(ALS)和胰岛素样生长因子(IGF)结合蛋白-3是糖蛋白,它们形成一种复合物,携带约90%的循环IGF。本研究通过Northern杂交研究大鼠中ALS表达的调控,并通过放射免疫分析研究血清ALS水平。对成年大鼠脑、心、肺、肌肉、脾、睾丸或卵巢、肾和肝的ALS信使核糖核酸(mRNA)进行Northern分析,显示肝脏中有一种主要的2千碱基转录本。与成年肝脏相比,新生和断奶大鼠肝脏中大鼠ALS mRNA的稳态丰度大大降低,其年龄依赖性与大鼠血清ALS水平相似。禁食24或48小时会降低血清IGF-I和ALS水平,但不会降低肝脏ALS mRNA水平。链脲佐菌素诱导的糖尿病大鼠,未治疗或用人GH治疗5天,血清ALS水平和肝脏ALS mRNA丰度显著降低。胰岛素治疗可使血清ALS正常化,但不能完全恢复ALS mRNA。地塞米松是肝细胞合成ALS的抑制剂,可显著降低血清ALS和肝脏ALS mRNA水平。禁食和糖尿病时肝脏表达与血清ALS水平之间的差异表明存在一种复杂的调节机制,其中翻译水平或更后期的事件可能与基因表达或mRNA稳定性的调节同样重要。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验